Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms

Area of Science:

• Neuroscience
• Psychopharmacology
• Medical History

Background:

• Psychedelics are ancient psychoactive substances historically used for spiritual experiences.
• Lysergic acid diethylamide (LSD) synthesis in 1937 and accidental discovery in 1943 spurred early research.
• Political factors led to bans in 1966, limiting psychedelic research until a recent 'Psychedelic Renaissance'.

Purpose of the Study:

• To provide a historical overview of psychedelic use and research.
• To examine the pharmacology, focusing on 5-HT2A receptor agonism.
• To compare potential therapeutic applications against associated risks.

Main Methods:

• Historical analysis of psychedelic research and societal context.
• Pharmacological review of psychedelic mechanisms of action.
• Comparative assessment of therapeutic benefits versus potential harms.

Main Results:

• Psychedelics interact with the 5-HT2A receptor, producing profound psychological effects.
• Potential therapeutic uses include depression, PTSD, anxiety, addiction, neurodegenerative, and autoimmune diseases.
• Potential harms include tolerance, Hallucinogen Persisting Perception Disorder, and psychosis risk.

Conclusions:

• The therapeutic potential of psychedelics appears to significantly outweigh their risks.
• Further international research and clinical trials are essential for regulatory approval.
• Reconsidering psychedelics for clinical use is supported by historical and pharmacological evidence.